skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 11,084  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world
Material Type:
Article 		Add to My Research

Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world

Cancer science, 2020-12, Vol.111 (12), p.4465-4479 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association ;2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14650 ;PMID: 32936975

Full text available

Citations Cited by
2
Dosimetry tools and techniques for IMRT
Dosimetry tools and techniques for IMRT
Material Type:
Article 		Add to My Research

Dosimetry tools and techniques for IMRT

Medical physics (Lancaster), 2011-03, Vol.38 (3), p.1313-1338 [Peer Reviewed Journal]

American Association of Physicists in Medicine ;2011 American Association of Physicists in Medicine ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1118/1.3514120 ;PMID: 21520843 ;CODEN: MPHYA6

Full text available

Citations Cited by
3
The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management
The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management
Material Type:
Article 		Add to My Research

The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management

Medical physics (Lancaster), 2016-07, Vol.43 (7), p.4209-4262 [Peer Reviewed Journal]

American Association of Physicists in Medicine ;2016 American Association of Physicists in Medicine ;2016 American Association of Physicists in Medicine. 2016 American Association of Physicists in Medicine ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1118/1.4947547 ;PMID: 27370140 ;CODEN: MPHYA6

Full text available

Citations Cited by
4
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial
Material Type:
Article 		Add to My Research

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial

Journal of clinical oncology, 2021-03, Vol.39 (7), p.787-796 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.02873 ;PMID: 33471548

Full text available

Citations Cited by
5
Tolerance limits and methodologies for IMRT measurement‐based verification QA: Recommendations of AAPM Task Group No. 218
Tolerance limits and methodologies for IMRT measurement‐based verification QA: Recommendations of AAPM Task Group No. 218
Material Type:
Article 		Add to My Research

Tolerance limits and methodologies for IMRT measurement‐based verification QA: Recommendations of AAPM Task Group No. 218

Medical physics (Lancaster), 2018-04, Vol.45 (4), p.e53-e83 [Peer Reviewed Journal]

2018 American Association of Physicists in Medicine ;2018 American Association of Physicists in Medicine. ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1002/mp.12810 ;PMID: 29443390

Full text available

Citations Cited by
6
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Material Type:
Article 		Add to My Research

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Journal of clinical oncology, 2020-04, Vol.38 (10), p.1019-1029 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02767 ;PMID: 32058845

Full text available

Citations Cited by
7
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial
Material Type:
Article 		Add to My Research

Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial

Journal of clinical oncology, 2020-12, Vol.38 (35), p.4175-4183 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.00650 ;PMID: 32840419

Full text available

Citations Cited by
8
Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning
Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning
Material Type:
Article 		Add to My Research

Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning

Head & neck, 2014-11, Vol.36 (11), p.1541-1546 [Peer Reviewed Journal]

2014 Wiley Periodicals, Inc. ;ISSN: 1043-3074 ;EISSN: 1097-0347 ;DOI: 10.1002/hed.23477 ;PMID: 23996502 ;CODEN: HEANEE

Full text available

Citations Cited by
9
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Material Type:
Article 		Add to My Research

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

The lancet oncology, 2015-12, Vol.16 (16), p.1605-1616 [Peer Reviewed Journal]

Wilkins et al. Open Access article distributed under the terms of CC BY ;2015 Wilkins et al. Open Access article distributed under the terms of CC BY ;Copyright © 2015 Wilkins et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Dec 2015 ;2015 Wilkins et al. Open Access article distributed under the terms of CC BY 2015 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00280-6 ;PMID: 26522334 ;CODEN: LANCAO

Full text available

Citations Cited by
10
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Material Type:
Article 		Add to My Research

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

The lancet oncology, 2022-10, Vol.23 (10), p.1308-1320 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00517-4 ;PMID: 36113498

Full text available

Citations Cited by
11
Analysis of the applicability of two‐dimensional detector arrays in terms of sampling rate and detector size to verify scanned intensity‐modulated proton therapy plans
Analysis of the applicability of two‐dimensional detector arrays in terms of sampling rate and detector size to verify scanned intensity‐modulated proton therapy plans
Material Type:
Article 		Add to My Research

Analysis of the applicability of two‐dimensional detector arrays in terms of sampling rate and detector size to verify scanned intensity‐modulated proton therapy plans

Medical physics (Lancaster), 2020-09, Vol.47 (9), p.4589-4601 [Peer Reviewed Journal]

2020 American Association of Physicists in Medicine ;2020 American Association of Physicists in Medicine. ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1002/mp.14346 ;PMID: 32574383

Full text available

Citations Cited by
12
Technical Note: Integrating an open source Monte Carlo code “MCsquare” for clinical use in intensity‐modulated proton therapy
Technical Note: Integrating an open source Monte Carlo code “MCsquare” for clinical use in intensity‐modulated proton therapy
Material Type:
Article 		Add to My Research

Technical Note: Integrating an open source Monte Carlo code “MCsquare” for clinical use in intensity‐modulated proton therapy

Medical physics (Lancaster), 2020-06, Vol.47 (6), p.2558-2574 [Peer Reviewed Journal]

2020 American Association of Physicists in Medicine ;2020 American Association of Physicists in Medicine. ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1002/mp.14125 ;PMID: 32153029

Full text available

Citations Cited by
13
Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
Material Type:
Article 		Add to My Research

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution

The oncologist (Dayton, Ohio), 2022-02, Vol.27 (1), p.40-47 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyab006 ;PMID: 35305097

Full text available

Citations Cited by
14
Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes
Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes
Material Type:
Article 		Add to My Research

Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes

Head & neck, 2016-04, Vol.38 (S1), p.E1886-E1895 [Peer Reviewed Journal]

2015 Wiley Periodicals, Inc. ;ISSN: 1043-3074 ;EISSN: 1097-0347 ;DOI: 10.1002/hed.24341 ;PMID: 26705956

Full text available

Citations Cited by
15
Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans
Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans
Material Type:
Article 		Add to My Research

Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans

Medical physics (Lancaster), 2012-11, Vol.39 (11), p.6868-6878 [Peer Reviewed Journal]

American Association of Physicists in Medicine ;2012 American Association of Physicists in Medicine ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1118/1.4757927 ;PMID: 23127079 ;CODEN: MPHYA6

Full text available

Citations Cited by
16
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
Material Type:
Article 		Add to My Research

Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost

Oncotarget, 2015-11, Vol.6 (35), p.38381-38397

Copyright: © 2015 Ou et al. 2015 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.5420 ;PMID: 26485757

Full text available

Citations Cited by
17
Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer
Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer
Material Type:
Article 		Add to My Research

Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

BMC cancer, 2023-05, Vol.23 (1), p.481-481 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10931-1 ;PMID: 37245053

Full text available

Citations Cited by
18
Knowledge‐based planning for intensity‐modulated radiation therapy: A review of data‐driven approaches
Knowledge‐based planning for intensity‐modulated radiation therapy: A review of data‐driven approaches
Material Type:
Article 		Add to My Research

Knowledge‐based planning for intensity‐modulated radiation therapy: A review of data‐driven approaches

Medical physics (Lancaster), 2019-06, Vol.46 (6), p.2760-2775 [Peer Reviewed Journal]

2019 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. ;This article is protected by copyright. All rights reserved. ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1002/mp.13526 ;PMID: 30963580

Full text available

Citations Cited by
19
Flattening filter free in intensity‐modulated radiotherapy (IMRT) – Theoretical modeling with delivery efficiency analysis
Flattening filter free in intensity‐modulated radiotherapy (IMRT) – Theoretical modeling with delivery efficiency analysis
Material Type:
Article 		Add to My Research

Flattening filter free in intensity‐modulated radiotherapy (IMRT) – Theoretical modeling with delivery efficiency analysis

Medical physics (Lancaster), 2019-01, Vol.46 (1), p.34-44 [Peer Reviewed Journal]

2018 American Association of Physicists in Medicine ;2018 American Association of Physicists in Medicine. ;ISSN: 0094-2405 ;EISSN: 2473-4209 ;DOI: 10.1002/mp.13267 ;PMID: 30371944

Full text available

Citations Cited by
20
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Material Type:
Article 		Add to My Research

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

Journal of clinical oncology, 2017-01, Vol.35 (1), p.56-62 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.69.1378 ;PMID: 28034064

Full text available

Citations Cited by

Results 1 - 20 of 11,084  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (10,463)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1999  (19)
  2. 1999 To 2004  (117)
  3. 2005 To 2010  (2,174)
  4. 2011 To 2017  (5,629)
  5. After 2017  (3,139)
  6. More options open sub menu

Language 

  1. English  (10,917)
  2. Japanese  (1,234)
  3. German  (58)
  4. Chinese  (35)
  5. Portuguese  (18)
  6. French  (14)
  7. Korean  (12)
  8. Turkish  (12)
  9. Persian  (11)
  10. Spanish  (10)
  11. Czech  (5)
  12. Norwegian  (4)
  13. Russian  (3)
  14. Polish  (2)
  15. Lithuanian  (1)
  16. Arabic  (1)
  17. Croatian  (1)
  18. Swedish  (1)
  19. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait